[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"PeptiDream PDRadiopharma and Curium Group Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan #biotech #news"
X Link @BCBionetwork 2025-10-15T15:50Z 1481 followers, XX engagements
"🎯 Presentations from PeptiDream / PDRadiopharma at #EANM2025 in Barcelona successfully concluded We shared results from our CA9-targeted theranostic peptide program including first-in-human imaging data. Proud of our team and this exciting step forward in nuclear medicine"
X Link @MasatoMurakami5 2025-10-06T04:21Z XX followers, XXX engagements
"📢 At #EANM2025 in Barcelona we will present results on PeptiDreams CA9-targeted peptide: 🔹 Preclinical data 🔹 First-in-human imaging data A milestone in peptide-based theranostics. #Radiopharma #Theranostics #CA9 #PDRPharma #PeptiDream"
X Link @MasatoMurakami5 2025-10-02T21:10Z XX followers, XXX engagements
"📹We are excited to announce that we will be presenting the Group's proprietary program PD-32766 at #EANM25 this weekend PD-32766 is a peptide-based theranostic agent targeting CA9 currently under development for ccRCC. #radiopharmaceutical #theranostics #RCC #CA9 #CAIX"
X Link @PeptidreamInc 2025-10-02T02:14Z XX followers, XXX engagements